Lv54
1118 积分 2024-06-07 加入
French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025
1天前
待确认
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
12天前
已完结
Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 Study
1个月前
已完结
Time to Loss of Disease Control following Guselkumab Withdrawal in Relation to Initial Speed of Response: A post hoc Analysis of the VOYAGE 2 Trial
1个月前
已关闭
Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab
1个月前
已完结
Differential Pharmacodynamic Effects on Psoriatic Biomarkers by Guselkumab Versus Secukinumab Correlate with Long-Term Efficacy: An ECLIPSE Substudy
1个月前
已完结
Early inadequate response to biological agents portends treatment failure at 6 months in patients with psoriasis: a multicenter, prospective cohort study
2个月前
已完结
The Phenomenon of Anti-Drug Antibodies in Psoriasis: Mechanisms, Clinical Impact, and Therapeutic Strategies
2个月前
已完结
Evaluation of Psoriasis Area and Severity Index, Static Physician's Global Assessment, and Lattice System-Physician's Global Assessment for assessing severity of psoriasis
3个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
4个月前
已完结
皖公网安备34019202002308
